Evidence

Surveillance report 2016 – Medicines adherence (2009) NICE guideline CG76

Surveillance decision

Surveillance decision

We will not update the guideline at this time.

We will transfer the guideline to the static list because:

  • No evidence was identified that would impact on the current guidance and no major ongoing studies or research have been identified as due to be published in the near future (that is, within the next 3–5 years).

Reason for the decision

We found 115 studies through surveillance of this guideline.

This included new evidence on patient involvement in decisions about medicines, supporting adherence and reviewing medicines that supports current recommendations. We asked topic experts whether this new evidence would affect current recommendations on NICE guideline CG76. Generally, the topic experts thought that an update was not needed.

We did not find any new evidence on communication between health professionals.

None of the new evidence considered in surveillance of this guideline was thought to have an effect on current recommendations.

In addition, no major ongoing studies or research due to be published in the next 3–5 years was identified.

Other clinical areas

We did not find any new evidence in areas not covered by the original guideline.

Equalities

No equalities issues were identified during the surveillance process.

Overall decision

After considering all the new evidence and views of topic experts, we decided that no update is necessary for this guideline.

See how we made the decision for further information.


This page was last updated: